Litcius/Paper detail

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection

David N. Juurlink

2020Canadian Medical Association Journal247 citationsDOIOpen Access PDF

Abstract

KEY POINTS Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the globe in recent months. With deaths from its associated disease, coronavirus disease 2019 (COVID-19), projected to reach into the millions and a vaccine unlikely in the near term, the search is on

Topics & Concepts

HydroxychloroquineAzithromycinChloroquineCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus2019-20 coronavirus outbreakVirologyPandemicBetacoronavirusDiseaseIntensive care medicineImmunologyOutbreakMalariaInfectious disease (medical specialty)Internal medicineBiologyMicrobiologyAntibioticsCOVID-19 Clinical Research StudiesInfectious Encephalopathies and EncephalitisSARS-CoV-2 and COVID-19 Research
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection | Litcius